✦ LIBER ✦

Salvage with erlotinib plus bevacizumab: not in NSCLC

✍ Scribed by Jean-Paul Sculier; Anne-Pascal Meert; Thierry Berghmans

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib plus bevacizumab in previously

✍ David M. Jackman; Hedy L. Kindler; Beow Y. Yeap; Panos Fidias; Ravi Salgia; Joan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Phase 2 study of bevacizumab plus erloti

✍ Philip A. Philip; Michelle R. Mahoney; Kyle D. Holen; Donald W. Northfelt; Henry 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

Targeted therapy with erlotinib prolongs

✍ James R. Rigas; Konstantin H. Dragnev 📂 Article 📅 2005 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 171 KB

Retreatment with erlotinib in NSCLC harb

✍ Fiala, Ondrej; Pesek, Milos; Finek, Jindrich; Benesova, Lucie; Minarik, Marek 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

VeriStrat® classifier for survival and t

✍ Carbone, David P.; Salmon, J. Stuart; Billheimer, Dean; Chen, Heidi; Sandler, Al 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 182 KB

53 ERLOTINIB TREATMENT IN A PATIENT WITH

✍ M. Montrone; B. Perrucci; C. Lotesoriere; M. Bruno; F. Fanelli; S. Pisconti 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB